Literature DB >> 12904626

Treatment of severe acute respiratory syndrome with convalescent plasma.

T Burnouf, M Radosevich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12904626

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN： 1024-2708            Impact factor:   2.227


× No keyword cloud information.
  21 in total

1.  Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants.

Authors:  Jianhua Sui; Wenhui Li; Anjeanette Roberts; Leslie J Matthews; Akikazu Murakami; Leatrice Vogel; Swee Kee Wong; Kanta Subbarao; Michael Farzan; Wayne A Marasco
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 2.  Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.

Authors:  Ponraj Prabakaran; Zhongyu Zhu; Xiaodong Xiao; Arya Biragyn; Antony S Dimitrov; Christopher C Broder; Dimiter S Dimitrov
Journal:  Expert Opin Biol Ther       Date:  2009-03       Impact factor: 4.388

3.  Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).

Authors:  Mavanur R Suresh; Pravin K Bhatnagar; Dipankar Das
Journal:  J Pharm Pharm Sci       Date:  2008-04-19       Impact factor: 2.327

4.  Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

Authors:  Chenguang Shen; Zhaoqin Wang; Fang Zhao; Yang Yang; Jinxiu Li; Jing Yuan; Fuxiang Wang; Delin Li; Minghui Yang; Li Xing; Jinli Wei; Haixia Xiao; Yan Yang; Jiuxin Qu; Ling Qing; Li Chen; Zhixiang Xu; Ling Peng; Yanjie Li; Haixia Zheng; Feng Chen; Kun Huang; Yujing Jiang; Dongjing Liu; Zheng Zhang; Yingxia Liu; Lei Liu
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

5.  Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19.

Authors:  Guillermo León; María Herrera; Mariángela Vargas; Mauricio Arguedas; Andrés Sánchez; Álvaro Segura; Aarón Gómez; Gabriela Solano; Eugenia Corrales-Aguilar; Kenneth Risner; Aarthi Narayanan; Charles Bailey; Mauren Villalta; Andrés Hernández; Adriana Sánchez; Daniel Cordero; Daniela Solano; Gina Durán; Eduardo Segura; Maykel Cerdas; Deibid Umaña; Edwin Moscoso; Ricardo Estrada; Jairo Gutiérrez; Marcos Méndez; Ana Cecilia Castillo; Laura Sánchez; Ronald Sánchez; José María Gutiérrez; Cecilia Díaz; Alberto Alape
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

6.  Therapeutic antibodies: current state and future trends--is a paradigm change coming soon?

Authors:  Dimiter S Dimitrov; James D Marks
Journal:  Methods Mol Biol       Date:  2009

7.  Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach.

Authors:  Michela Flego; Paola Di Bonito; Alessandro Ascione; Silvia Zamboni; Alessandra Carattoli; Felicia Grasso; Antonio Cassone; Maurizio Cianfriglia
Journal:  BMC Infect Dis       Date:  2005-09-19       Impact factor: 3.090

8.  Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.

Authors:  Jan ter Meulen; Edward N van den Brink; Leo L M Poon; Wilfred E Marissen; Cynthia S W Leung; Freek Cox; Chung Y Cheung; Arjen Q Bakker; Johannes A Bogaards; Els van Deventer; Wolfgang Preiser; Hans Wilhelm Doerr; Vincent T Chow; John de Kruif; Joseph S M Peiris; Jaap Goudsmit
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

Review 9.  Treatment algorithm for COVID-19: a multidisciplinary point of view.

Authors:  Felice Galluccio; Tolga Ergonenc; Alvaro Garcia Martos; Abdallah El-Sayed Allam; Maria Pérez-Herrero; Ricardo Aguilar; Giacomo Emmi; Michele Spinicci; Ignacio Terrancle Juan; Mario Fajardo-Pérez
Journal:  Clin Rheumatol       Date:  2020-05-29       Impact factor: 2.980

Review 10.  The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.

Authors:  John Mair-Jenkins; Maria Saavedra-Campos; J Kenneth Baillie; Paul Cleary; Fu-Meng Khaw; Wei Shen Lim; Sophia Makki; Kevin D Rooney; Jonathan S Nguyen-Van-Tam; Charles R Beck
Journal:  J Infect Dis       Date:  2014-07-16       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.